Once renal transplant recipients are stabilized and require less frequent follow-up with their transplant team, health care providers outside of the transplant setting play an integral role in patients' ongoing medical care. Given renal transplant recipients' inherent complexity, these health care providers often seek consult regarding decisions that may affect transplant-related medications or outcomes. In this review, we discuss answers to 10 of the questions commonly posed to our renal transplant team by other health care providers.
Keywords: HMG-CoA reductase inhibitors; angiotensin II receptor blockers; angiotensin converting enzyme inhibitors; antidepressants; drug interactions; drug safety; fluoroquinolones; herpes zoster; immunizations; immunosuppressant medications; renal transplant; skin malignancy; sodium-glucose cotransporter 2 inhibitors; urinary tract infection.